Trichomonas vaginalis metalloproteinase induces mTOR cleavage of SiHa cells
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Trichomonas vaginalis secretes a number of proteases which are suspected to be the cause of pathogenesis; however, little is understood how they manipulate host cells. The mammalian target of rapamycin (mTOR) regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis, and transcription. We detected various types of metalloproteinases including GP63 protein from T. vaginalis trophozoites, and T. vaginalis GP63 metalloproteinase was confirmed by sequencing and western blot. When SiHa cells were stimulated with live T. vaginalis, T. vaginalis excretory-secretory products (ESP) or T. vaginalis lysate, live T. vaginalis and T. vaginalis ESP induced the mTOR cleavage in both time- and parasite load-dependent manner, but T. vaginalis lysate did not. Pretreatment of T. vaginalis with a metalloproteinase inhibitor, 1,10-phenanthroline, completely disappeared the mTOR cleavage in SiHa cells. Collectively, T. vaginalis metallopeptidase induces host cell mTOR cleavage, which may be related to survival of the parasite.
Abstract
Trichomonas vaginalis secretes a number of proteases which are suspected to be the cause of pathogenesis; however, little is understood how they manipulate host cells. The mammalian target of rapamycin (mTOR) regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis, and transcription. We detected various types of metalloproteinases including GP63 protein from T. vaginalis trophozoites, and T. vaginalis GP63 metalloproteinase was confirmed by sequencing and western blot. When SiHa cells were stimulated with live T. vaginalis, T. vaginalis excretory-secretory products (ESP) or T. vaginalis lysate, live T. vaginalis and T. vaginalis ESP induced the mTOR cleavage in both time- and parasite load-dependent manner, but T. vaginalis lysate did not. Pretreatment of T. vaginalis with a metalloproteinase inhibitor, 1,10-phenanthroline, completely disappeared the mTOR cleavage in SiHa cells. Collectively, T. vaginalis metallopeptidase induces host cell mTOR cleavage, which may be related to survival of the parasite.
참고문헌 (23)
- Van der Pol B, "Trichomonas vaginalis infection : the most prevalent nonviral sexually transmitted infection receives the least public health attention", Clin Infect Dis, 44, pp.23~25 (2007)
- Gómez-Barrio A, "Biological variability in clinical isolates of Trichomonas vaginalis", Mem Inst Oswaldo Cruz, 97, pp.893~896 (2002)
- Poole DN, "Global epidemiology of Trichomonas vaginalis", Sex Transm Infect, 89, pp.418~422 (2013)
- Arroyo R, "Trichomonas vaginalis surface proteinase activity is necessary for parasite adherence to epithelial cells", Infect Immun, 57, pp.2991~2997 (1989)
- Hirt RP, "Trichomonas vaginalis surface proteins : a view from the genome", Trends Parasitol, 23, pp.540~547 (2007)
- Ma L, "Involvement of the GP63 protease in infection of Trichomonas vaginalis", Parasitol Res, 109, pp.71~79 (2011)
- Sommer U, "Identification of Trichomonas vaginalis cysteine proteases that induce apoptosis in human vaginal epithelial cells", J Biol Chem, 280, pp.23853~23860 (2005)
- Kulkarni MM, "Trypanosoma cruzi GP63 proteins undergo stage-specific differential posttranslational modification and are important for host cell infection", Infect Immun, 77, pp.2193~2200 (2009)
- Joshi PB, "Targeted gene deletion in Leishmania major identifies leishmanolysin(GP63)as a virulence factor", Mol Biochem Parasitol, 120, pp.33~40 (2002)
- Hay N, "Upstream and downstream of mTOR", Genes Dev, 18, pp.1926~1945 (2004)
- Dennis PB, "Mammalian TOR : a homeostatic ATP sensor", Science, 294, pp.1102~1105 (2001)
- Edinger AL, "Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake", Mol Biol Cell, 13, pp.2276~2288 (2002)
- Jaramillo M, "Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection", Cell Host Microbe, 9, pp.331~341 (2011)
- Cao W, "Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway", Nat Immunol, 9, pp.1157~1164 (2008)
- Polivka J Jr, "Molecular targets for cancer therapy in the PI3K", AKT, Pharmacol Ther, pp.2014, 142[DOI]
- Alvarez-Sánchez ME, "A novel cysteine proteinase(CP65)of Trichomonas vaginalis involved in cytotoxicity", Microb Pathog, 28, pp.193~202 (2000)
- Galbaugh T, "EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation", BMC Cell Biol, 7, pp.34~ (2006)
- Vignot S, "mTOR-targeted therapy of cancer with rapamycin derivatives", Ann Oncol, 16, pp.525~537 (2005)
- Matte C, "Disruption of the AKT", mTOR pathway by Leishmania major promastigotes, 2011, pp.5(suppl 1), 44~
- Isnard A, "Impact of Leishmania metalloprotease GP63 on macrophage signaling", Front Cell Infect Microbiol, 2, pp.72~ (2012)
- Slomovitz BM, "The PI3K", AKT, Clin Cancer Res, pp.2012, 18[DOI]
- Park KR, "β-caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K", AKT, S6K1 pathways and ROS-mediated MAPKs activation, pp.Cancer Lett, 2011[DOI]
- Pathania AS, "Disruption of the PI3K", AKT, Food Chem Toxicol, pp.2013, 62[DOI]